LETM2

gene
On this page

Also known as FLJ25409SLC55A2

Summary

LETM2 (leucine zipper and EF-hand containing transmembrane protein 2, HGNC:14648) is a protein-coding gene on chromosome 8p11.23, encoding LETM1 domain-containing protein LETM2, mitochondrial (Q2VYF4).

Predicted to enable transmembrane transporter activity. Predicted to be involved in mitochondrial calcium ion transmembrane transport and mitochondrion organization. Located in mitochondrion.

Source: NCBI Gene 137994 — RefSeq curated summary.

At a glance

  • GWAS associations: 12
  • Clinical variants (ClinVar): 72 total
  • MANE Select transcript: NM_001286819

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:14648
Approved symbolLETM2
Nameleucine zipper and EF-hand containing transmembrane protein 2
Location8p11.23
Locus typegene with protein product
StatusApproved
AliasesFLJ25409, SLC55A2
Ensembl geneENSG00000165046
Ensembl biotypeprotein_coding
OMIM620380
Entrez137994

Gene structure

Transcript identifiers

Ensembl transcripts: 17 — 11 protein_coding, 3 retained_intron, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000297720, ENST00000379957, ENST00000518121, ENST00000518883, ENST00000519476, ENST00000523268, ENST00000523983, ENST00000524874, ENST00000526075, ENST00000526356, ENST00000527175, ENST00000527334, ENST00000527710, ENST00000528827, ENST00000530448, ENST00000889546, ENST00000948387

RefSeq mRNA: 9 — MANE Select: NM_001286819 NM_001199659, NM_001199660, NM_001286787, NM_001286819, NM_001286821, NM_001330515, NM_001363204, NM_001363205, NM_144652

CCDS: CCDS56534, CCDS6106, CCDS69466, CCDS75731, CCDS83282

Canonical transcript exons

ENST00000379957 — 11 exons

ExonStartEnd
ENSE000015274733839409838394241
ENSE000018061273839254238392995
ENSE000021227673838647638386568
ENSE000035263543840027238400409
ENSE000035269823840085338401053
ENSE000035280643840252538402644
ENSE000035361873840736238407463
ENSE000035428963840439338404506
ENSE000035890663840694638407038
ENSE000036611053838795038388030
ENSE000039013863840821238409527

Expression profiles

Bgee: expression breadth ubiquitous, 173 present calls, max score 90.16.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.7601 / max 249.4772, expressed in 1515 samples.

FANTOM5 promoters (11 alternative TSS)

Promoter IDTPM avgSamples expressed
884904.57931280
884951.5223414
884971.0469312
884930.4509198
884960.2946112
884940.2878129
884860.263295
884890.152253
884880.092939
884870.048424

Top tissues by expression

239 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453390.16gold quality
right testisUBERON:000453489.49gold quality
cerebellar hemisphereUBERON:000224589.26gold quality
cerebellar cortexUBERON:000212989.02gold quality
right hemisphere of cerebellumUBERON:001489088.85gold quality
testisUBERON:000047387.59gold quality
cerebellumUBERON:000203786.66gold quality
secondary oocyteCL:000065580.90gold quality
islet of LangerhansUBERON:000000678.05gold quality
descending thoracic aortaUBERON:000234577.30gold quality
adenohypophysisUBERON:000219676.01gold quality
stromal cell of endometriumCL:000225575.94gold quality
cortical plateUBERON:000534375.87gold quality
oocyteCL:000002375.78gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047375.70gold quality
right coronary arteryUBERON:000162575.62gold quality
left uterine tubeUBERON:000130375.61gold quality
anterior cingulate cortexUBERON:000983575.54gold quality
leukocyteCL:000073875.41gold quality
body of pancreasUBERON:000115075.39gold quality
omental fat padUBERON:001041475.24gold quality
right frontal lobeUBERON:000281075.17gold quality
peritoneumUBERON:000235875.15gold quality
granulocyteCL:000009475.13gold quality
pancreasUBERON:000126475.00gold quality
monocyteCL:000057674.98gold quality
thoracic aortaUBERON:000151574.77gold quality
ascending aortaUBERON:000149674.72gold quality
Brodmann (1909) area 9UBERON:001354074.39gold quality
lower esophagus muscularis layerUBERON:003583374.26gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

46 targeting LETM2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-126-5P100.0072.713180
HSA-MIR-200B-3P100.0073.312693
HSA-MIR-200C-3P100.0073.352685
HSA-MIR-429100.0073.442698
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-453499.9966.581907
HSA-MIR-19A-3P99.9875.332762
HSA-MIR-19B-3P99.9875.442754
HSA-MIR-808299.9567.271170
HSA-MIR-464899.9167.00710
HSA-MIR-6739-5P99.8067.872806
HSA-MIR-6733-5P99.7467.942759
HSA-MIR-471999.7372.103329
HSA-MIR-464399.4967.631791
HSA-MIR-203A-3P99.4970.562806
HSA-MIR-608199.4866.071446
HSA-MIR-132499.4666.571302
HSA-MIR-516A-3P99.4667.961378
HSA-MIR-516B-3P99.4667.961378
HSA-MIR-7162-5P99.4668.081368
HSA-MIR-4735-5P99.4368.491780
HSA-MIR-94099.3766.142064
HSA-MIR-6808-5P99.3166.232150
HSA-MIR-6893-5P99.3166.252119
HSA-MIR-5584-3P99.2368.791351
HSA-MIR-140-3P99.0467.691324

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerioletm2ENSDARG00000077515
mus_musculusLetm2ENSMUSG00000037363
rattus_norvegicusLetm2ENSRNOG00000026180

Paralogs (2): LETMD1 (ENSG00000050426), LETM1 (ENSG00000168924)

Protein

Protein identifiers

LETM1 domain-containing protein LETM2, mitochondrialQ2VYF4 (reviewed: Q2VYF4)

Alternative names: LETM1 and EF-hand domain-containing protein 2, Leucine zipper-EF-hand-containing transmembrane protein 1-like

All UniProt accessions (8): A8K1M9, E5RJN4, E5RK40, Q2VYF4, E9PIC7, E9PMA4, E9PN52, H0YCZ8

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Mitochondrion inner membrane.

Isoforms (4)

UniProt IDNamesCanonical?
Q2VYF4-11yes
Q2VYF4-22
Q2VYF4-33
Q2VYF4-44

RefSeq proteins (9): NP_001186588, NP_001186589, NP_001273716, NP_001273748, NP_001273750, NP_001317444, NP_001350133, NP_001350134, NP_653253 (=MANE)

Domains & families (InterPro)

IDNameType
IPR033122LETM1-like_RBDDomain
IPR044202LETM1/MDM38-likeFamily
IPR045742LETM2_NDomain

Pfam: PF07766, PF19324

UniProt features (17 total): splice variant 4, compositionally biased region 3, topological domain 2, region of interest 2, transit peptide 1, chain 1, sequence conflict 1, transmembrane region 1, domain 1, coiled-coil region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q2VYF4-F162.770.15

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 106 (showing top): GSE45365_NK_CELL_VS_CD8_TCELL_UP, SHEPARD_BMYB_MORPHOLINO_UP, CREBP1_Q2, GOBP_MONOATOMIC_CATION_TRANSPORT, CREB_Q4, E4F1_Q6, GOCC_MITOCHONDRIAL_ENVELOPE, AACTTT_UNKNOWN, SENESE_HDAC1_TARGETS_UP, GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT, GOBP_TRANSMEMBRANE_TRANSPORT, GOCC_ORGANELLE_INNER_MEMBRANE, MARSON_BOUND_BY_FOXP3_STIMULATED, YATGNWAAT_OCT_C, GOMF_RIBONUCLEOPROTEIN_COMPLEX_BINDING

GO Biological Process (2): mitochondrial calcium ion transmembrane transport (GO:0006851), mitochondrion organization (GO:0007005)

GO Molecular Function (2): transmembrane transporter activity (GO:0022857), ribosome binding (GO:0043022)

GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
calcium ion transmembrane transport1
organelle organization1
transporter activity1
transmembrane transport1
ribonucleoprotein complex binding1
cytoplasm1
intracellular membrane-bounded organelle1
organelle inner membrane1
mitochondrial membrane1
cellular anatomical structure1

Protein interactions and networks

STRING

947 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
LETM2GOT1L1Q8NHS2567
LETM2NSD3Q9BZ95553
LETM2RAB11FIP1Q6WKZ4543
LETM2BRF2Q9HAW0526
LETM2DDHD2O94830522
LETM2SIRAL2Q9NWS6491
LETM2PLPP5Q8NEB5478
LETM2MICU1Q9BPX6462
LETM2RHBDD3Q9Y3P4461
LETM2BAG4O95429448
LETM2TACC1O75410448
LETM2PLPBPO94903448
LETM2REEP6Q96HR9446
LETM2DNAJC18Q9H819427
LETM2LSM1O15116420

IntAct

6 interactions, top by confidence:

ABTypeScore
GABARAPL1psi-mi:“MI:0914”(association)0.350
ATG16L1psi-mi:“MI:0914”(association)0.350
LETM2GAPDHSpsi-mi:“MI:0914”(association)0.350
LETM1LETM2psi-mi:“MI:0914”(association)0.350
LETM2EIF3CLpsi-mi:“MI:0914”(association)0.350

BioGRID (78): LETM2 (Synthetic Lethality), GAPDHS (Affinity Capture-MS), TCTEX1D2 (Affinity Capture-MS), PNMA2 (Affinity Capture-MS), LETM2 (Cross-Linking-MS (XL-MS)), LETM2 (Cross-Linking-MS (XL-MS)), LETM2 (Affinity Capture-MS), AHNAK (Affinity Capture-MS), AK4 (Affinity Capture-MS), AMOT (Affinity Capture-MS), AP2A2 (Affinity Capture-MS), APMAP (Affinity Capture-MS), ARL6IP5 (Affinity Capture-MS), ARPC4 (Affinity Capture-MS), ASAH1 (Affinity Capture-MS)

ESM2 similar proteins: A2VD95, A4UMC5, D6WIX5, E7EXT2, O13920, O95202, P70302, P84903, P91927, P91928, Q06493, Q08CK1, Q0P4W3, Q0VA06, Q0VCA3, Q13586, Q1KKT4, Q1L987, Q1LY46, Q28DA8, Q29RR5, Q2VYF4, Q3ZC62, Q498P2, Q58CP9, Q5FW14, Q5PQQ5, Q5RAS1, Q5RJT2, Q5U2Y6, Q5XIN6, Q5ZK33, Q5ZKM1, Q66JD1, Q6DI35, Q6PFM4, Q7TNU7, Q7ZU80, Q7ZYV9, Q80X82

Diamond homologs: O13920, O95202, P91927, Q06493, Q08179, Q0VA06, Q0VCA3, Q1LY46, Q28DA8, Q2VYF4, Q5PQQ5, Q5XIN6, Q5ZK33, Q7TNU7, Q9Z2I0

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

72 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance61
Likely benign2
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

1840 predictions. Top by Δscore:

VariantEffectΔscore
8:38401051:G:GTdonor_gain1.0000
8:38401051:GAA:Gdonor_gain1.0000
8:38401054:G:GGdonor_gain1.0000
8:38402519:TTTCA:Tacceptor_loss1.0000
8:38402520:TTCA:Tacceptor_loss1.0000
8:38402522:CA:Cacceptor_loss1.0000
8:38402523:A:AGacceptor_gain1.0000
8:38402523:AG:Aacceptor_loss1.0000
8:38402524:G:GAacceptor_gain1.0000
8:38402524:GAT:Gacceptor_gain1.0000
8:38402524:GATA:Gacceptor_gain1.0000
8:38402642:G:GTdonor_gain1.0000
8:38402642:GAGG:Gdonor_loss1.0000
8:38402645:GCA:Gdonor_loss1.0000
8:38402646:CAA:Cdonor_loss1.0000
8:38404383:C:Aacceptor_gain1.0000
8:38404391:A:AGacceptor_gain1.0000
8:38404391:AGT:Aacceptor_gain1.0000
8:38404391:AGTG:Aacceptor_gain1.0000
8:38404392:G:GAacceptor_gain1.0000
8:38404392:GT:Gacceptor_gain1.0000
8:38404392:GTG:Gacceptor_gain1.0000
8:38404392:GTGG:Gacceptor_gain1.0000
8:38404392:GTGGC:Gacceptor_gain1.0000
8:38404502:GGGAG:Gdonor_gain1.0000
8:38404503:GGAG:Gdonor_gain1.0000
8:38404503:GGAGG:Gdonor_gain1.0000
8:38404504:GAG:Gdonor_gain1.0000
8:38404504:GAGG:Gdonor_gain1.0000
8:38404505:AGG:Adonor_loss1.0000

AlphaMissense

3191 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
8:38404393:T:AW369R0.994
8:38404393:T:CW369R0.994
8:38404395:G:CW369C0.990
8:38404395:G:TW369C0.990
8:38402568:T:CL343P0.989
8:38401016:T:CL316P0.988
8:38402637:T:CL366P0.988
8:38400950:T:CL294P0.986
8:38402625:T:CL362P0.986
8:38401048:G:CD327H0.985
8:38400324:T:CL233P0.984
8:38402595:T:CM352T0.980
8:38404403:T:CL372P0.979
8:38404421:T:AV378D0.978
8:38400320:T:CF232L0.977
8:38400322:T:AF232L0.977
8:38400322:T:GF232L0.977
8:38394099:T:CL168P0.976
8:38401004:T:CL312P0.976
8:38401049:A:TD327V0.976
8:38394221:T:CF209L0.974
8:38394223:T:AF209L0.974
8:38394223:T:GF209L0.974
8:38402589:G:CR350P0.974
8:38404436:T:CL383S0.973
8:38400959:T:CL297P0.972
8:38402576:G:CA346P0.972
8:38401048:G:TD327Y0.971
8:38401049:A:CD327A0.971
8:38401028:T:CL320P0.970

dbSNP variants (sampled 300 via entrez): RS1000202792 (8:38392005 G>T), RS1000365460 (8:38402697 T>C), RS1000448269 (8:38387358 G>C), RS1000497460 (8:38397607 T>C,G), RS1000592143 (8:38408799 G>A,T), RS1000633807 (8:38402167 G>A,C), RS1000670706 (8:38408714 C>G,T), RS1000871328 (8:38388752 T>G), RS1000891603 (8:38383604 T>A), RS1000944339 (8:38388434 C>G), RS1001117987 (8:38391277 T>C), RS1001143624 (8:38380917 A>G), RS1001224889 (8:38405059 G>C), RS1001277831 (8:38382209 G>A), RS1001305087 (8:38404841 G>A,C)

Disease associations

OMIM: gene MIM:620380 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

12 associations (top):

StudyTraitp-value
GCST003469_12Response to cognitive-behavioural therapy in anxiety disorder4.000000e-06
GCST004521_242Autism spectrum disorder or schizophrenia4.000000e-09
GCST004946_16Schizophrenia1.000000e-11
GCST006803_65Schizophrenia6.000000e-10
GCST007201_408Schizophrenia1.000000e-06
GCST007201_97Schizophrenia1.000000e-12
GCST007269_277Pulse pressure2.000000e-11
GCST008103_171Bipolar disorder7.000000e-06
GCST009600_31Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)2.000000e-09
GCST90000025_329Appendicular lean mass1.000000e-21
GCST90002387_394Immature fraction of reticulocytes8.000000e-15
GCST90002388_241Lymphocyte count8.000000e-15

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0007820cognitive behavioural therapy
EFO:0005763pulse pressure measurement
EFO:0004980appendicular lean mass
EFO:0004587lymphocyte count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — SLC55 Mitochondrial cation/proton exchangers

CTD chemical–gene interactions

31 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
(+)-JQ1 compounddecreases expression, increases expression2
Benzo(a)pyreneincreases expression2
Smokedecreases expression, increases expression2
Cyclosporineincreases expression2
aristolochic acid Iincreases expression1
triphenyl phosphateaffects expression1
bisphenol Aaffects cotreatment, increases methylation1
2-methyl-4-isothiazolin-3-oneincreases expression1
beta-lapachoneincreases expression1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
butyraldehydeincreases expression1
potassium chromate(VI)decreases expression1
pentanalincreases expression1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic acidincreases expression1
monomethylarsonous acidincreases expression1
abrineincreases expression1
Fulvestrantaffects cotreatment, increases methylation1
Leflunomideincreases expression1
Acetaminophendecreases expression1
Dichlorodiphenyl Dichloroethyleneincreases expression1
Diethylhexyl Phthalatedecreases expression1
Quercetinincreases expression1
Silicon Dioxideincreases expression1
Theophyllinedecreases expression1
Tobacco Smoke Pollutionincreases expression1
Vanadatesincreases expression1
Aflatoxin B1increases expression1
Cadmium Chlorideincreases expression1
Copper Sulfateincreases expression1

Cellosaurus cell lines

2 cell lines: 2 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_D4G1HCT116-LETM2-KO-c11Cancer cell lineMale
CVCL_D4G2HCT116-LETM2-KO-c2Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.